Jungmeen Kim-Spoon1, Nina Lauharatanahirun1,2,3,4, Kristin Peviani1, Alexis Brieant1, Kirby Deater-Deckard5, Warren K Bickel1,2, Brooks King-Casas1,2. 1. Department of Psychology, Virginia Tech, Blacksburg, VA, USA. 2. Virginia Tech Carilion Research Institute, Blacksburg, VA, USA. 3. U.S. Army Research Laboratory, Aberdeen Proving Ground, Aberdeen, MD, USA. 4. Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA. 5. Department of Psychological and Brain Sciences, University of Massachusetts, Amherst, MA, USA.
Abstract
BACKGROUND: Current theories in neuroscience emphasize the crucial role of individual differences in the brain contributing to the development of risk taking during adolescence. Yet, little is known about developmental pathways through which family risk factors are related to neural processing of risk during decision making, ultimately contributing to health risk behaviors. Using a longitudinal design, we tested whether neural risk processing, as affected by family multi-risk index, predicted delay discounting and substance use. METHOD: One hundred and fifty-seven adolescents (aged 13-14 years at Time 1, 52% male) were assessed annually three times. Family multi-risk index was measured by socioeconomic adversity, household chaos, and family risk-taking behaviors. Delay discounting was assessed by a computerized task, substance use by questionnaire data, and risk-related neural processing by blood-oxygen-level-dependent (BOLD) responses in the amygdala during a lottery choice task. RESULTS: Family multi-risk index at Time 1 was related to adolescent substance use at Time 3 (after controlling for baseline substance use) indirectly through heightened amygdala sensitivity to risks and greater delay discounting. CONCLUSIONS: Our results elucidate the crucial role of neural risk processing in the processes linking family multi-risk index and the development of substance use. Furthermore, risk-related amygdala activation and delay discounting are important targets in the prevention and treatment of substance use among adolescents growing up in high-risk family environments.
BACKGROUND: Current theories in neuroscience emphasize the crucial role of individual differences in the brain contributing to the development of risk taking during adolescence. Yet, little is known about developmental pathways through which family risk factors are related to neural processing of risk during decision making, ultimately contributing to health risk behaviors. Using a longitudinal design, we tested whether neural risk processing, as affected by family multi-risk index, predicted delay discounting and substance use. METHOD: One hundred and fifty-seven adolescents (aged 13-14 years at Time 1, 52% male) were assessed annually three times. Family multi-risk index was measured by socioeconomic adversity, household chaos, and family risk-taking behaviors. Delay discounting was assessed by a computerized task, substance use by questionnaire data, and risk-related neural processing by blood-oxygen-level-dependent (BOLD) responses in the amygdala during a lottery choice task. RESULTS: Family multi-risk index at Time 1 was related to adolescent substance use at Time 3 (after controlling for baseline substance use) indirectly through heightened amygdala sensitivity to risks and greater delay discounting. CONCLUSIONS: Our results elucidate the crucial role of neural risk processing in the processes linking family multi-risk index and the development of substance use. Furthermore, risk-related amygdala activation and delay discounting are important targets in the prevention and treatment of substance use among adolescents growing up in high-risk family environments.
Authors: Michael W Arthur; John S Briney; J David Hawkins; Robert D Abbott; Blair L Brooke-Weiss; Richard F Catalano Journal: Eval Program Plann Date: 2007-01-26
Authors: Matthew W Johnson; Warren K Bickel; Forest Baker; Brent A Moore; Gary J Badger; Alan J Budney Journal: Exp Clin Psychopharmacol Date: 2010-02 Impact factor: 3.157
Authors: Juliane H Fröhner; Stephan Ripke; Sarah Jurk; Shu-Chen Li; Tobias Banaschewski; Arun L W Bokde; Erin Burke Quinlan; Sylvane Desrivières; Herta Flor; Antoine Grigis; Hugh Garavan; Andreas Heinz; Rüdiger Brühl; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Eric Artiges; Frauke Nees; Dimitri Papadopoulos Orfanos; Luise Poustka; Sarah Hohmann; Henrik Walter; Robert Whelan; Gunter Schumann; Michael N Smolka Journal: Alcohol Clin Exp Res Date: 2022-03-17 Impact factor: 3.928
Authors: Michael J Sofis; Alan J Budney; Catherine Stanger; Ashley A Knapp; Jacob T Borodovsky Journal: Drug Alcohol Depend Date: 2019-12-23 Impact factor: 4.492
Authors: Sarah D Lichenstein; Corey Roos; Robert Kohler; Brian Kiluk; Kathleen M Carroll; Patrick D Worhunsky; Katie Witkiewitz; Sarah W Yip Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2021-03-09
Authors: Steven J Nieto; Alexandra Venegas; Elizabeth M Burnette; James MacKillop; Lara A Ray Journal: Psychopharmacology (Berl) Date: 2021-10-15 Impact factor: 4.415